What You Need to Know About Zofran® Birth Defects
December 1st, 2015|
Morning Sickness and the Medications That Treat It
Estimates show almost half of all women experience nausea and vomiting during the early stages of pregnancy. The condition, known as morning sickness, can be treated with a variety of medications. However, some of these drugs may cause harm to an unborn child.
In 1991, the U.S. Food and Drug Administration approved the drug Zofran for the treatment of nausea and vomiting for surgical patients and cancer patients undergoing chemotherapy. The drug was never approved to treat morning sickness in pregnant women.
Lack of approval didn’t stop the makers of Zofran from marketing the drug to those experiencing morning sickness, though.
Off-Label Marketing of Zofran®
Many pregnant women prescribed Zofran say they were never warned about the risks to their unborn children by doctors or the medication’s manufacturer. Reports of babies being born with birth defects began to surface after the off-label marketing began.
Some of the Zofran birth defects that were reported include:
- Cleft lip
- Cleft palate
- Heart defects
- Kidney problems
If you took Zofran during pregnancy and your child was born with a birth defect, the drug injury attorneys at Norris Injury Lawyers encourage you to get help. Learn more about the options and resources available to those harmed by the drug Zofran.